INSIGHTS ON CLINICAL TRIAL DESIGN
-
Breaking Barriers In Drug Development: Time, Trust And Putting Patients First
Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.
-
AI's Bottleneck In Clinical Trials Moved, And Most People Missed It
AI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting
The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.
-
Evidence Of An Industry's Readiness To Collaborate11/13/2024
The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.
-
Improving The eCOA Experience1/25/2026
Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.
-
Disclosure Management System: Build Or Buy?6/19/2025
Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.
-
The Real Payoff Of Reusable IRT/RTSM System Design2/27/2026
By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.
-
The Secret Sauce Behind High-Enrolling PIs7/16/2026
The real challenge with enrollment often comes at the screening stage, where PI prioritization, site bandwidth, and sponsor support guide how many patients actually make it onto a study.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.
-
Advarra can serve as your partner for everything from single investigational sites to multisite research consortia and therapeutic networks.
-
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.